In an era in which medicine is moving towards precision medicine, in which tailor-made treatments are sought, CIDETEC's biomaterials group is working on the design and synthesis of different drug delivery systems based on polymeric nanoparticles, nanoemulsions, and combining lipids and polymers that adapt to these needs.
Thus, in the design of our delivery platforms, we take into account the delivery method, the different barriers to be faced and the type of drug to be transported.
Antimicrobial resistance is already a reality, and CIDETEC is developing drug delivery systems to improve the properties of some antibiotics by improving their stability, reducing their toxicity, modifying their kinetics, or even combining them with enzymes to degrade the biofilm.
In this sense, we have been working for several years on the design and synthesis of nanoantibiotics, which have been tested in pneumonia models or recently in post-surgery infection problems.
Advanced therapies and gene therapies are opening endless possibilities to address the treatment of certain diseases in an innovative way.
However, the use of viral vectors has certain limitations due to their scalability and safety. For this reason, CIDETEC is researching the development of new platforms for RNA encapsulation, using polyplexes, nanoemulsions and lipopolyplexes, among others.
CIDETEC has an interdisciplinary research group that includes experts in polymers and colloids, bioengineers, biochemists and pharmacists, to develop technology specially designed for delivery through the skin.
The aim of this line of research is to design delivery systems that, deliver ingredients precisely where they are needed, based on an understanding of the skin.
In addition, an important line of action includes the development of more environmentally friendly systems, for which we are working on biodegradable emulsifiers.
CIDETEC develops biomaterials based on hydrogels and bioactive coatings for application in medical devices.
In this line, we mainly work in two research areas, traumatology and ophthalmology, where hydrogels play an important role.
We also have an extensive network of collaborations at European level as we participate in two Open Innovation Test Beds promoted by the European Commission (TBMED, MDOT) for the development of medical devices.
The cosmetics sector is not oblivious to the need to generate efficient and more environmentally friendly products.
CIDETEC Nanomedicine develops multifunctional and biodegradable colloids to improve the efficacy of cosmetic ingredients. Using natural polymers, we obtain environmentally friendly encapsulation systems.